India’s Bioeconomy Boom: From $10 Billion to $165.75 Billion in a Decade

India’s bioeconomy has seen extraordinary growth over the last decade, expanding from $10 billion in 2014 to $165.75 billion by 2024.

This sixteen-fold growth is not just a statistical feat—it marks a broader transformation driven by the country’s vision of aligning biotechnology with sustainability, digital innovation, and inclusive development.

With a contribution of 4.25% to the national GDP and a CAGR of 17.9% over the last 4 years, India’s bioeconomy is becoming a critical pillar in its aspiration to be a knowledge-led, future-ready economy.

What is the Bioeconomy?

At its core, the bioeconomy involves the sustainable use of renewable biological resources—such as crops, animals, and microbes—to produce food, energy, and industrial goods. It integrates cutting-edge technologies such as gene editing and bioprinting with the principles of the circular economy.

The goal is to reduce dependence on fossil fuels, enhance food and health security, and create eco-friendly alternatives for a range of products.

India’s Vision for a Thriving Bioeconomy

India’s roadmap for the bioeconomy is ambitious yet grounded in innovation-led, inclusive growth. It aims to emerge as a global hub for biomanufacturing by investing in R&D, nurturing talent, and building infrastructure. 

A target of achieving a $300 billion bioeconomy by 2030 has been set, with special emphasis on areas like bio-pharma, diagnostics, vaccines, and sustainable industrial biotechnology. This effort is part of the broader India@2047 vision that emphasises green growth and self-reliance.

BioE3 Policy: Biotechnology for Economy, Environment, and Employment

The BioE3 Policy, approved in August 2024, is a strategic leap in transforming India into a global biotechnology leader. It promotes high-performance biomanufacturing while addressing economic development, environmental sustainability, and employment generation.

Key Highlights:

• Green Manufacturing: Encourages a shift from chemical-based industries to bio-based alternatives with low carbon footprints.

• Circular Bioeconomy: Supports regenerative models aligned with net-zero emission goals.

• Infrastructure Development: Proposes bio-foundries, bio-AI hubs, and advanced biomanufacturing centres to facilitate product development.

• Job Creation: Focuses on generating employment, especially in tier-II and tier-III cities.

• Global Standards: Emphasises biosafety and regulatory alignment to enhance global competitiveness.

National Biopharma Mission: Driving Biotech Excellence

The National Biopharma Mission (NBM) – Innovate in India (i3), launched by the Department of Biotechnology and implemented by BIRAC, aims to strengthen India’s biopharmaceutical sector. With a $250 million budget (half funded by the World Bank), the mission supports public-private partnerships to foster innovation in vaccines, biosimilars, and diagnostics.

Notable Achievements:

• 11 shared testing and manufacturing facilities established

• Over 1,000 new jobs created

• Support for more than 100 projects across 150 organisations

• Development of the world’s first DNA COVID-19 vaccine

• India now manufactures 65% of the world’s vaccines

• Initiatives underway for the first indigenous HPV vaccine

Agricultural Biotechnology: A New Green Revolution

Agriculture is a key area where biotechnology is making a tangible impact. Innovations under the Department of Biotechnology’s Agricultural programme are reshaping Indian farming practices.

Highlights:

• SAATVIK Chickpea: Drought-resistant and high-yielding, now approved for cultivation.

• Edited Rice Varieties: Gene-edited rice lines showing improved yields.

• SNP Arrays: Tools like IndRA (for rice) and IndCA (for chickpea) help in genetic profiling.

• Nano Biocontrol: Environmentally friendly solution to powdery mildew in tomatoes and grapes.

• Kisan-Kavach: A pesticide-protective suit improving farmer safety.

Biotech-KISAN: Empowering Farmers Through Innovation

The Biotech-Krishi Innovation Science Application Network (Biotech-KISAN) fosters a collaborative environment between scientists and farmers. The programme is particularly focused on women, rural communities, and tribal areas.

Features:

• Operates in 115 Aspirational Districts

• Uses a hub-and-spoke model to spread innovation

• Encourages region-specific scientific interventions

BIRAC: The Backbone of Biotech Startups

Established in 2012, the Biotechnology Industry Research Assistance Council (BIRAC) is instrumental in nurturing India’s biotech startup ecosystem. Through incubation, funding, and mentoring, BIRAC has enabled innovation across a wide spectrum of biotech areas.

Key Initiatives:

• BIG (Biotechnology Ignition Grant): Up to ₹50 lakh for early-stage innovation

• SEED Fund: ₹30 lakh for proof-of-concept stage startups

• LEAP Fund: ₹100 lakh to support commercialisation

• जनCARE Challenge: Boosting digital health solutions in tier-II, III, and rural India. 

Conclusion: A Bio-Enabled Future for India

India’s bioeconomy story is a blend of policy support, technological advancement, and inclusive innovation. As the country looks ahead to 2030 with the goal of reaching a $300 billion bioeconomy, the focus remains on balancing growth with sustainability.

From affordable healthcare and green manufacturing to precision agriculture and digital health, the biotechnology sector is setting the foundation for India’s next economic leap—one that is resilient, inclusive, and environmentally conscious.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks; read all the related documents carefully before investing.